Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Metadata
Title
Advances in pharmacologic agents in imaging: New A2A receptor agonists
Author
Manuel D. Cerqueira, MD
Publication date
01-03-2006
Publisher
Current Medicine Group
Published in
Current Cardiology Reports / Issue 2/2006
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-006-0022-1

Other articles of this Issue 2/2006

Current Cardiology Reports 2/2006 Go to the issue

OriginalPaper

Valvular heart disease in pregnancy

OriginalPaper

Imaging cardiac neuronal function and dysfunction

OriginalPaper

Carcinoid heart disease

OriginalPaper

Approach to the patient with aortic stenosis and low ejection fraction

OriginalPaper

Web alert

OriginalPaper

Noninvasive monitoring of medical therapy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits